Forbion

About The Fund

Forbion is a venture capital firm headquartered in Naarden, the Netherlands, specializing in the life sciences sector. They work closely with entrepreneurs and build companies that aim to significantly impact healthcare and transform people's lives. With a clear focus on Biotech, HealthTech, Medical Devices, Healthcare, Investment Management, Life Sciences, Oncology, Consumer Healthcare, and Pharmaceuticals, Forbion's expertise is in equity investments, ranging from seed to Series B stages. They have an investment sweet spot of approximately €1,500,000, while their minimum investment is about €100,000 and their maximum can go up to €5,000,000. Forbion manages over €1 billion in assets and their specialties are not only in funding but also in empowering entrepreneurs, working with scientists, and collaborating with academic institutions. Forbion's strategic vision also encompasses sustainability and responsible investment, exemplified by their commitment as a signatory to the United Nations Principles for Responsible Investment, and their venture with BioGeneration Ventures, which focuses on seed and early-stage funds specifically in Benelux and Germany. They are also involved in initiatives directed towards cleaning and feeding the planet through their BioEconomy strategy. The Forbion team, featuring an array of professionals from partners to associates, operates collaboratively, leveraging their operational and management expertise to review transactions and drive growth in their portfolio companies. Some of Forbion's featured companies include Amphista Therapeutics, Prilenia Therapeutics, Verdiva Bio, and BioInvent which span across different innovative sectors like targeted protein degradation, clinical-stage biotech, and immuno-modulatory antibodies for cancer treatment.